Order Article Reprints

Liu H, Wei P, Aviszus K, Zhang Q, Linderberger J, Yang J, Liu J, Chen Z, Waheed H, Reynoso L, et al. The Receptor Binding Domain of SARS-CoV-2 Lambda Variant Has a Better Chance Than the Delta Variant in Evading BNT162b2 COVID-19 mRNA Vaccine-Induced Humoral Immunity. International Journal of Molecular Sciences. 2022; 23(19):11325. https://doi.org/10.3390/ijms231911325

Liu, Haolin, Pengcheng Wei, Katja Aviszus, Qianqian Zhang, Jared Linderberger, John Yang, Junfeng Liu, Zhongzhou Chen, Hassan Waheed, Lyndon Reynoso, and et al. 2022. "The Receptor Binding Domain of SARS-CoV-2 Lambda Variant Has a Better Chance Than the Delta Variant in Evading BNT162b2 COVID-19 mRNA Vaccine-Induced Humoral Immunity" International Journal of Molecular Sciences 23, no. 19: 11325. https://doi.org/10.3390/ijms231911325

Liu, H., Wei, P., Aviszus, K., Zhang, Q., Linderberger, J., Yang, J., Liu, J., Chen, Z., Waheed, H., Reynoso, L., Downey, G. P., Frankel, S. K., Kappler, J. W., Marrack, P., & Zhang, G. (2022). The Receptor Binding Domain of SARS-CoV-2 Lambda Variant Has a Better Chance Than the Delta Variant in Evading BNT162b2 COVID-19 mRNA Vaccine-Induced Humoral Immunity. International Journal of Molecular Sciences, 23(19), 11325. https://doi.org/10.3390/ijms231911325